Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1999
12/29/1999EP0966958A1 Aerosol preparation
12/29/1999EP0966952A1 Liquid products containing erythritol
12/29/1999EP0966496A1 Method for gelling aqueous media, use of copolyesters as gelling agents of aqueous media and novel copolyesters for gelling aqueous media
12/29/1999EP0966481A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
12/29/1999EP0966431A1 Salicylic acid-sphingoid base derivatives and uses thereof
12/29/1999EP0966427A1 Preparation of acid amides and metallisation of compounds
12/29/1999EP0966304A1 Site-specific drug delivery
12/29/1999EP0966303A2 Polypeptide conjugates for transporting substances across cell membranes
12/29/1999EP0966299A2 Novel pharmaceutical compositions
12/29/1999EP0966295A1 Calcareous material
12/29/1999EP0966291A1 Medicinal preparation containing a lipophilic inert gas
12/29/1999EP0966273A2 Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties
12/29/1999EP0966272A1 Improved dosage units
12/29/1999EP0966270A1 Novel method for obtaining microspheres and resulting products
12/29/1999EP0966268A1 Cross-linked plant protein particles, in particular microparticles or nanoparticles, preparation method and cosmetic, pharmaceutical or food compositions containing same
12/29/1999EP0966207A1 Composition comprising a liquid absorbed on a support based on precipitate silica
12/29/1999EP0868716A4 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities
12/29/1999EP0813412B1 Gel for the local hormonotherapy of vaginal dryness
12/29/1999EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy
12/29/1999CN1239977A Stable aqueous dispersions and stable water-dispersible dry xanthophyll powder, their production and use
12/29/1999CN1239887A Pharmaceutical compositions containing N-sulphonyl indolin derivatives
12/29/1999CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy
12/29/1999CA2335956A1 Compounds obtained from salvia species having antiviral activity
12/29/1999CA2335636A1 Sticking plaster for controlled release of natural interferon
12/29/1999CA2333586A1 Matrix-type transdermal patch for steroid hormones
12/29/1999CA2332334A1 A polypeptide-polymer conjugate
12/29/1999CA2330189A1 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
12/29/1999CA2330026A1 Compositions and methods for delivery of agents for altering neuronal growth, regeneration, and survival
12/29/1999CA2328457A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
12/29/1999CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999CA2294075A1 Herbal extract composition and method with immune-boosting capability
12/29/1999CA2273408A1 Phytage formulation
12/28/1999US6008336 Compacted nucleic acids and their delivery to cells
12/28/1999US6008319 A permeability enhancing peptide that is free of cytokine activity and is joined to a delivery vehicle that targets tumors; therapy for increasing uptake of antitumor agents or tumor imaging agents
12/28/1999US6008256 Comprises (a) lidocaine, (b) epinephrine in specific amount, and (c) one or more amino acids; excellent storage stability
12/28/1999US6008249 Pharmaceutical, orally applicable composition
12/28/1999US6008228 Comprising a mixture of carrier monoglycerides of medium chain-fatty acids
12/28/1999US6008203 Administering a sialylated lactose carbohydrate compound antitumor agent
12/28/1999US6008198 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same
12/28/1999US6008192 Hydrophilic binary systems for the administration of lipophilic compounds
12/28/1999US6008191 Pharmaceutical compositions containing cyclosporin
12/28/1999US6008189 Intravaginal preparation containing physiologically active peptide
12/28/1999US6008187 A pill comprising sodium salicylate, and a pharmaceutically-acceptable oil for providing enhanced absorption of the polypeptide through the wall of the gastrointestinal tract
12/28/1999US6007843 Storage stable, sterile, pure mixture comprising active drug dispersed within polysaccharide matrix comprising blend of hyaluronic acid or salt and a nonionic polysaccharide where matrix is dissolved or suspended in liquid medium
12/28/1999US6007834 Nasal melatonin composition
12/28/1999US6007833 Crosslinkable macromers bearing initiator groups
12/28/1999US6007817 Vasopermeability enhancing immunoconjugates
12/28/1999US6007810 Chondroitinase compositions
12/28/1999US6007808 Nutrient mixture of eubiotic bacteria and glutamine or glutamine-containing polypeptide
12/28/1999US6007791 Stabilization of microspheres by preparation in aqueous solution containing an alpha-hydroxy acid and/or polyoxyethylene glycol derivative
12/28/1999CA2191862C Branched synthetic peptide conjugate
12/28/1999CA2177683C Tissue moisturizing and antimicrobial compositions
12/28/1999CA2099941C Method for producing sustained release microsphere preparation
12/28/1999CA2062375C Thickeners for products for topical application
12/28/1999CA2009687C Organosiloxane-containing polysaccharides
12/28/1999CA2000932C Oral pharmaceutical controlled release multiple unit dosage form
12/23/1999WO1999065936A2 Composition for the treatement of immune deficiencies and methods for its preparation and use
12/23/1999WO1999065930A1 Vitamin b12 derivatives and methods for their preparation
12/23/1999WO1999065599A1 Flowable preparations of the water-in-oil emulsion type having an increased water content
12/23/1999WO1999065598A1 Flowable preparations of the water-in-oil emulsion type having an increased water content
12/23/1999WO1999065538A1 Medical device having anti-infective and contraceptive properties
12/23/1999WO1999065531A1 Polymers for delivery of nucleic acids
12/23/1999WO1999065529A1 Nucleic acid-cobalamin complexes and their use in gene therapy
12/23/1999WO1999065528A1 Imprinted copolymers for selective adsorption of cholesterol
12/23/1999WO1999065527A1 Solution comprising prostaglandins and benzyl alcohol
12/23/1999WO1999065526A1 Topical ointment composition for burn treatment
12/23/1999WO1999065521A1 Methods and materials for the treatment of prostatic carcinoma
12/23/1999WO1999065513A2 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999WO1999065506A2 Cancer therapy with indolicidin or cationic peptides and their polymer conjugates
12/23/1999WO1999065505A1 Oregano for the treatment of internal parasites and protozoa
12/23/1999WO1999065497A1 Vaginal active agent delivery procedures and formulations thereof
12/23/1999WO1999065493A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
12/23/1999WO1999065471A1 Method for making tablets with active principle sustained-release
12/23/1999WO1999065469A2 Processes to generate submicron particles of water-insoluble compounds
12/23/1999WO1999065466A1 Temperature-sensitive liposomal formulation
12/23/1999WO1999065465A1 Method of forming liposomes
12/23/1999WO1999065463A1 Active ingredient delivery systems and devices based on porous matrices
12/23/1999WO1999065462A2 Use of aminosterol derivatives as chloride ionphores
12/23/1999WO1999065461A2 Cationic amphiphile micellar complexes
12/23/1999WO1999065460A2 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist
12/23/1999WO1999065454A1 Hydrous cosmetic or pharmaceutical sticks
12/23/1999WO1999065452A2 Hydrogels of water soluble polymers crosslinked by protein domains
12/23/1999WO1999065448A2 Cosmetic or dermopharmaceutical composition in the form of beads and methods for preparing same
12/23/1999WO1999065303A1 Composition and method for treating penile erectile dysfunction
12/23/1999WO1999051629A3 New compounds for dna-transfection
12/23/1999WO1999050398A3 Recombinant anti-tumor rnase
12/23/1999WO1999047168A3 Induction and enhancement of the immune response to type-2 t cell-independent antigens conjugated to lipid or lipid-containing moieties
12/23/1999DE19850768A1 Fließfähige Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt Flowable preparations emulsion type W / O with increased water content
12/23/1999DE19827732A1 Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms
12/23/1999DE19826793A1 Stable diminazene diaceturate preparation having antiprotozoal activity, used e.g. for treating malaria or trypanosomiasis
12/23/1999CA2335638A1 Cationic amphiphile micellar complexes
12/23/1999CA2335460A1 Polymers for delivery of nucleic acids
12/23/1999CA2335337A1 Methods and materials for the treatment of prostatic carcinoma
12/23/1999CA2335303A1 Pressurized metered dose inhalers and pharmaceutical aerosol formulations
12/23/1999CA2335255A1 Vaginal active agent delivery procedures and formulations thereof
12/23/1999CA2335183A1 Method of forming liposomes
12/23/1999CA2335055A1 Medical device having anti-infective and contraceptive properties
12/23/1999CA2334996A1 Active ingredient delivery systems and devices based on porous matrices
12/23/1999CA2334805A1 Use of aminosterol derivatives as chloride ionphores
12/23/1999CA2334598A1 Vitamin b12 derivatives and methods for their preparation
1 ... 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 ... 1712